Citi Leaves Boston Scientific Price Target Of $6.70 Unchanged (BSX)

Citi left its Boston Scientific BSX price target of $6.70 unchanged prior to its conference call with the company this morning, as stated in a research report published today. In the report, Citi states, "4Q10 EPS missed Street views when a $0.05 tax variance and lower R&D spend are factored in. Weak 2011 guidance means more trouble lies ahead in both pricing and volume trends and we expect another round of downward estimate revisions today." Shares of Boston Scientific were at $6.90 at the time of posting in pre-market trading, down 3.23% from Tuesday's market close.